A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
Completed · Phase 3 · Has a placebo group
Conditions studied: Type 2 Diabetes
In brief
The purpose of this study is to learn whether dapagliflozin, after 12 weeks, can improve (decrease) blood pressure in patients with type 2 diabetes with uncontrolled hypertension who are on an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker. The safety of this treatment will also be studied.
Key facts
- Study ID
- NCT01137474
- Run by
- AstraZeneca
- People needed
- 2996
- Starts
- 2010-07-01
- Expected to finish
- 2013-02-01
- Last updated by the study team
- 2017-01-26
Who can join
Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Horizon Research Group, Inc. — Mobile, Alabama, United States
- Iicr, Inc. (International Institute Of Clinical Research) — Ozark, Alabama, United States
- Hope Research Institute — Phoenix, Arizona, United States
- 43rd Medical Associates — Phoenix, Arizona, United States
- Central Phoenix Medical Clinic, Llc — Tempe, Arizona, United States
- Clinical Research Advantage/Desert Clinical Research — Tempe, Arizona, United States
- Visions Clinical Research - Tucson — Tucson, Arizona, United States
- Eclipse Clinical Research — Tucson, Arizona, United States
- Aureus Research, Inc. — Little Rock, Arkansas, United States
- Preferred Research Partners, Inc. — Little Rock, Arkansas, United States
- Orange County Research Institute — Anaheim, California, United States
- Cmp Research — Anaheim, California, United States
- Med Center — Carmichael, California, United States
- Catalina Research Institute, Llc — Chino, California, United States
- Southland Clinical Research Center, Inc. — Fountain Valley, California, United States
- Marin Endocrine Care & Research, Inc. — Greenbrae, California, United States
- Del Rosario Medical Clinic, Inc. — Huntington Park, California, United States
- Time Clinical Research Inc. — Huntington Park, California, United States
- Marina Raikhel, M.D., F.A.A.F.P — Lomita, California, United States
- Clinica Medica San Miguel — Los Angeles, California, United States
- American Institute Of Research — Los Angeles, California, United States
- Randall G. Shue, D.O. — Los Angeles, California, United States
- National Research Inst — Los Angeles, California, United States
- Quest Diagnostics West Hills — Los Angeles, California, United States
- University Of Alabama At Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.